Biotech Grand Prix 2021

NEWS

News

2024/10/14 Biotech Grand Prix 2024: Grand Prize Won by SPHinX

Grand Prix
News
Biotech Grand Prix

2024/10/09 Biotech Grand Prix 2024 to be held

News
Biotech Grand Prix

2024/04/08 TECH PLANTER revamps its logo and evolves into a mechanism to further accelerate business creation.

Agritech Grand Prix
Ecotech Grand Prix
Grand Prix
Deep Tech Grand Prix
News
Biotech Grand Prix
Food Tech Grand Prix
Marintec Grand Prix
Lifetech Grand Prix

2023/12/04 Tech Planter 2024 call for entries is now open!

Agritech Grand Prix
Ecotech Grand Prix
Grand Prix
Deep Tech Grand Prix
News
Biotech Grand Prix
Food Tech Grand Prix
Marintec Grand Prix
Lifetech Grand Prix

ABOUT

Outline of the event

point (e.g. of a statement)

Scientific and technological "seeds" are being created in universities, research institutes, and corporate laboratories, but it takes a lot of effort before they sprout into practical applications. The Tech Planter, organized by LIVERNESS and its partners, is an ecosystem that aims to serve as a planter to discover these seeds and help them sprout into business. The Biotech Grand Prix 2021 is a program aimed at discovering and fostering technology seeds and entrepreneurs in the real tech field (biotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.).

Related Grand Prix :. List of Biotech Grand Prix

subject (of taxation, etc.)

Those who have a vision to change the world or improve the world based on the technological seeds in the real tech field and have a will to establish or develop a new business.
Individuals and teams are both welcome to participate, even before incorporation.
No limitation on the number of years of establishment, even if you are already a corporation. Even if you are close to mass production or PMF establishment, if you are planning to collaborate with partner companies, etc., it is acceptable.

Application Theme

Healthcare, energy, and agriculture infrastructure

Application period

Monday, March 1, 2021 - Friday, July 9, 2021

Screening Criteria

A panel of judges composed of LIVERNESS and its partners will review the following items

01novelty (patentability)
02feasibility
03Are you going to change the world?
04passion

commendation

Grand Prize: (300,000 yen cash prize + right to receive 5 million yen business investment) 1
Corporate Prize: (200,000 yen) Approximately 10 prizes will be awarded.

SCHEDULE

Schedule

3/1[MON]: Entry Start

this way (direction close to the speaker or towards the speaker)Please register as a member and fill out the web form to apply. We also hold information sessions at universities and on an individual basis to encourage determination to enter and to teach tips on how to prepare documents. Please feel free to contact us for more information.

6/26[SAT]: kickoff

RIVANES and its partners, as well as entered teams, will meet and mingle.
Business consultation and partnership development with each other will be available. Participation or lack of participation on the day of the event will not be considered.

7/12[MON]: 1st round: Application Screening

A panel of judges composed of LIVERNESS and its partners will review the documents.
You will be asked to submit information about your team, skills, passions, and vision for the future via web form and video.
All applicants will be notified of the screening results and provided with feedback on their applications.
In addition, individual interviews (also online) for presentation review will be conducted for those who wish to participate.

8monthfirst 10 days of month: Finalists determined

Interviews will be held for applicants who pass the document screening to brush up their presentations for the final round.
In addition, meetings can be set up with partner companies for the purpose of business consultation and developing partnerships.

9/25[SAT]: Biotech Grand Prix

The 12 finalist teams that pass the document screening will be screened for presentation.

10Month～: Matching Support Period

After the Demo Day, the contact point between the venture and LIBANES will continue to be open for discussions on commercialization.
We handle a wide range of start-up issues, from incorporation to prototype development, financing, R&D, and more.
In addition, collaborative matching between ventures and partner companies has become more active to support business development.

PARTNER

ASSET

asset

ASSET01Riverness Communicator
ASSET02Partners
ASSET03Professional Supporter
ASSET04superfactory group

SUPPORT

Support

SUPPORT01Organize the purpose and vision of starting a business
SUPPORT02Brush up on your presentation
SUPPORT03Providing opportunities for business company collaboration
SUPPORT04Support for R&D and prototype development
SUPPORT05Support for knowledge and IP strategies
SUPPORT06finance

DEMO DAY

Grand Prix Outline

Grand Prix Name

Biotech Grand Prix 2021

Location

Center of Garage (1-16-3 Yokogawa, Sumida-ku, Tokyo)

Date & Time

Saturday, September 25, 2021, 13:00-19:00

Application period

Monday, March 1, 2021 - Friday, July 9, 2021

Participation Target

Held on a closed, pre-registration basis (finalists, partner companies, professional supporters, Super Factory Group)

organizing

Leave a Nest Co., Ltd.

timeline

12:30-13:00: inauguration
13:00-13:30: Greetings from the Organizer
13:30～16:50: Final Selection Presentations (Presenter①~⑫)
16:50-17:50: Review Time
17:50-19:00: Announcement of Judging Results and Award Ceremony

JUDGE

judge

head judge
Vice President CTO and Representative Director, Liverness, Inc.
Inoue, Jyo

D., Pharmacist, Tokyo University of Pharmacy and Life Sciences. He is a founding member of LIVERNESS. D. in pharmacology from Tokyo University of Pharmacy and Life Sciences, and a founding member of LIVANESS. While conducting research and development, he is responsible for launching joint research projects with universities and research institutions and supporting the establishment of research institutes.
Asahi Quality and Innovations, Ltd.General Manager, New Business Development Dept.
Masatake Maeda

Graduated from the Graduate School of Agriculture, Kyoto University in 1998, and joined Kyowa Hakko Kogyo Co. Ltd. where he was engaged in the development of fermentation production processes for pharmaceuticals and food ingredients as a fermentation process researcher. From 2011, he was stationed in Singapore and Italy to oversee the pharmaceutical and food ingredients business in Asia, Africa, Europe, and the Middle East. Currently promoting new business development activities at Asahi Quality and Innovations.
Manager, Bio-Solutions Section, Next Generation Business Development and Promotion Department, EBARA CORPORATION
Kei Masui

Joined the EBARA Group in 1997. Since joining the EBARA Group in 1997, he has worked mainly as an engineer for plants for private sector demand. He was also involved in EPC projects for private demand during his assignment in Southeast Asia. He is mainly involved in bio-energy projects.
Suntory Global Innovation Center LimitedSenior Researcher, Research Promotion Division
Tomohiro Maekawa

Born in Osaka. Patent Attorney. Joined Koyo Seiko Corporation (now JTEKT Corporation) in 1998, where he was in charge of development and design of electric power steering systems. In 2003, he joined Suntory Limited, where he was in charge of intellectual property strategy for production equipment, PET bottles and other containers, and beer in the Intellectual Property Department. 20 years later, he became a patent attorney. In the Intellectual Property Department, he was in charge of intellectual property strategies for production facilities, PET bottles and other containers, and beer. Promoted open innovation in the field of fundamental research.
General Manager, Clinical Planning Division 2, CPCC, Inc.
Mitsuhiro Fujimoto

After graduating from Chuo University, he joined BML Co. where he was mainly engaged in clinical laboratory sales, sales of electronic medical record systems, and sanitation management for companies involved in food products. He then joined CPCC Corporation in 2011. He is responsible for designing clinical research together with researchers, who are the sponsors of clinical research, by establishing and improving a system for systematic and efficient recruitment of study volunteers, which is essential for clinical research, to gain a foothold in the field.
Global Tobacco Business R&D Principal Scientist, Japan Tobacco Inc.

Hiroki Shikata

After completing his Master's degree in Chemistry at the University of Tokyo, he joined Japan Tobacco Inc. in 1989. He was engaged in research related to chemical sensory perception, such as taste and smell, and spent two years as a Visiting Scientist at the Monell Institute for Chemical Sensory Research in 1995. After returning to Japan, he worked on the development of D-spec (low odor tobacco products) technology, which was incorporated into more than 20 brands of products. After that, he served as Director of the R&D Planning Department, Director of the Product Development Engineering Department, and Director of the Central Tobacco Research Institute before assuming his current position in 2019. D. (Human Science).
General Manager, General Technology Research Center, Nihon Unisys, Ltd.
Aiko Kabayashi

Joined Nihon Unisys Software (currently integrated into Nihon Unisys) in 1998. Since joining the company, he has been involved in the development of many web-front systems, regardless of industry or business category. After that, he joined an organization specializing in UI/UX design, where he focused on promoting and educating the application of user-centered design, which emphasizes the user's perspective.
Leader, Medical Business Strategy Group, New Healthcare Business Development Office, Mitsui Chemicals, Inc.
Yusuke Yoshida

Graduated from Waseda University School of Law in 1998. After working for Sumitomo Chemical and Deloitte Tohmatsu Consulting, he joined Mitsui Chemicals in 2011, where he led the acquisition of a German dental materials manufacturer as project leader in 2013. He was stationed at Mitsui Chemicals, where he led business development and acquisitions as Vice President, and served as CTO for the last two years of his six-year tenure, managing product planning and development projects.
Executive Officer, Meiji Holdings Co.
Managing Executive Officer, General Manager, Research Division, Meiji Co.
Shigeru Taniguchi

Graduated from the Department of Agricultural Chemistry, Faculty of Agriculture, Kobe University in 1982, and joined Meiji Dairies Corporation in the same year. After joining the company, he was engaged in research and development of pharmaceuticals and milk and dairy products. Ltd. in 2011, and after serving as General Manager of Dairy Products Product Planning Department, Dairy Products Unit, Meiji Corporation, he has been in his current position since June 2019. At the Value Co-Creation Center of Meiji Holdings, he is engaged in promoting anti-aging research and strengthening immune enhancement research. He has served as Vice President of the International Life Science Research Organization and Vice Chairman of the Health Food Industry Council.
Chief Strategist, Production & Supply Chain Strategic Design Division, Rohto Pharmaceutical Co.

Yoshie Ogakiuchi

MSc in Financial Economics (University of London), PhD in Economics (University of Essex). In 2017, he joined Rohto Pharmaceutical Co. In 2017, he joined Rohto Pharmaceutical Co., Ltd. in the Corporate Planning Department, where he was in charge of leading investment-related and company-wide business reform programs before assuming his current position in 2020. He is mainly involved in DX promotion related to production, human resource development, and production-driven business creation.

FINALIST

finalist

Heinz Tech Co.

Representative] Mutsuko Aoki

Nanostructure system for highly efficient introduction and extraction of intracellular substances
Develops and sells tools using composite nanotube thin films and systems for using them, which enable highly efficient introduction of arbitrary substances into and extraction of substances from cells, which have been difficult to achieve with conventional methods.
Nihon Unisys BIPROGY Award / Mitsui Chemicals Award

Sothys Technologies, Inc.

Representative] Kazuhito Tabata

Single molecule detection that anyone can do!
By incorporating state-of-the-art technology called digital assay, which can detect a single protein, a single DNA molecule, or a single virus particle, into a technology that can be used by both children and adults, we offer an improvement in life through the use of ultra-sensitive detection.
D Amino Acid Labs, Inc.

Representative] Takeshi Kurono

Business development using D-amino acid-producing lactic acid bacteria
D-amino acids have not been industrially utilized as much as L-amino acids. We focus on D-amino acids, which may have important physiological functions, and aim to implement D-amino acids in society through both rapid analytical methods and functional foods.
Meiji Holdings Award

BIOTA Corporation

Representative] Kohei Ito

Sustainable and healthy urban environment created by microbial diversity
Developed GreenAir, a microorganism spraying device to improve indoor environment. With the vision of "creating a society in which microorganisms coexist in harmony," the company uses microbiome genome analysis and probiotic technology to improve the quality of life of people living in Japan.
Live Cell Diagnosis, Inc.

Representative] Mai Yamagishi

Cellular Response Observation Techniques for Understanding Individual Differences and Differences among Individuals
LCI-S, a microscopic observation technology using near-field light, has been developed to observe in real time at the single-cell level what message substances are secreted by cells taken from living organisms. This technology will be implemented in society to realize the ultimate in personalized medicine.
Real Tech Fund Award

AutoPhagyGO, Inc.

Representative] Miwako Ishido

Industrial Application of Autophagy Research Results
Autophagy regulates cell regeneration by degrading intracellular self-components. Based on the latest research results on this core mechanism of life span regulation, we aim to contribute to healthy longevity in a wide range of healthcare, prevention, and treatment fields.
Shin Art Co.

Representative] Shinichiro Shoji

Manufacturing through the fusion of synthetic biology and synthetic chemistry
By accurately capturing and integrating the fields of expertise in synthetic biology and synthetic chemistry, the company will work to create new value in manufacturing, such as healthcare materials that contribute to the prevention and treatment of unmet human diseases, and material materials that combine high performance and sustainability.
Grand Prize / AQI Award

B-Lab

Representative] Kazuya Koumoto

Novel additives based on biological properties change extraction and synthesis
A new additive focused on environmental adaptation of organisms in extreme environments can change the water network structure and dissolve difficult-to-water-soluble substances in water up to tens of thousands of times. Using this function, we aim to realize extraction of active ingredients and chemical synthesis without using organic solvents.
Suntory Prize

C-HAS

Representative] Tsuyoshi Suto

C Elegance Healthy Life Expectancy Measurement Technology to Explore Healthy Materials
Aiming to realize a society with extended healthy life expectancy by searching and evaluating anti-aging ingredients that maintain unaffected diseases with C-HAS, the C-Elegance Healthy Life Span Mini-Population Analysis Technology. The company will develop a business centered on the identification of new anti-aging ingredients and contracted evaluation of existing natural ingredients.
CPCC Award

HPM (Health Promotion from Mouth )

Representative] Hiroyasu Kanetaka

Health Monitoring with Oral Biometric Detection and AI
Monitoring biological information from saliva and bacterial flora in the oral cavity for prevention and early detection of systemic diseases. Dentistry and engineering will collaborate to develop sensoring devices, AI technology, etc. to measure ions, cortisol levels, etc. that affect health status.
JT Prize

Noise for Human

Representative] Masato Odagaki

Improved health and function produced by noise stimulation
At first glance, "noise" is regarded as an obstacle. By providing the brain and body with a weak electric current (noise) that is imperceptible to the human body, the system can be used for rehabilitation training for dementia patients and to control a person's ability to concentrate.
EBARA Award / Roth Award

Insect Techno Sensor

Representative] Hidefumi Mitsuno

Visualization of foreign odor components by insect olfactory "sensor cells
Focusing on the olfactory receptors of insects, which have an amazing sense of smell, we have developed "sensor cells" that capture odors as fluorescent changes. The aim is to create sensor cells that can detect various odor components in the environment, and to visualize the strange odors that occur in objects.